In the present study, the induction of drug-metabolizing enzymes and transporters was evaluated by analyzing mRNA expression in human hepatocytes after exposure to various compounds. The compounds tested included typical enzyme inducers, rifampicin and omeprazole, and controls. All experiments were performed in the presence of 0.1％ DMSO. Analysis was performed by the real-time reverse-transcription polymerase chain reaction method (RT PCR) in the presence of TaqMan probes using an ABI PRISM 7700 Sequence Detector system. A new analytic method to quantify mRNA levels in small numbers of human hepatocytes has been developed for phase I enzymes, phase II enzymes, and transporters. The levels of CYP1A1, CYP2B6, CYP2C8, CYP3A4, CYP3A5, ADH3, and ABCG1 mRNA in human hepatocytes increased after exposure to rifampicin. The levels of CYP1A1, CYP2B6, CYP3A4, CYP3A5, and ABCG1 mRNA recovered after a change to media without rifampicin. The levels of CYP1A1, CYP1A2, CYP1B1, ALDH3, and ALDH6 mRNA increased after exposure to omeprazole, and recovered after a change to media without omeprazole. On the other hand, the levels of ADH3 and ABCB4 mRNA decreased after exposure to omeprazole, and recovered after a change to media without omeprazole. In conclusion, these results demonstrate the applicability of quantitative real-time RT PCR to the evaluation of the gene induction and recovery of drug-metabolizing enzymes and transporters after exposure to drugs in human hepatocytes.
INTRODUCTION
Drug-drug interactions are an important consideration in drug development. However, species diŠer-ences in the inhibition and induction of drugmetabolizing enzymes are frequently observed in the metabolism of xenobiotics. Interestingly, the induction of CYP3A4 in human hepatocytes by several model compounds has been found not to correlate with the induction of CYP3A1/2 in rat hepatocytes. 1) Studies employing human tissues are useful in overcoming this problem. Primary culture of human hepatocytes represents a unique in vitro system for studying the potential of drugs to induce phase I and phase II enzymes involved in drug metabolism. It has been demonstrated that human hepatocytes can be cryopreserved and thawed without signiˆcant loss of the activities of the major cytochrome P450 isoforms or the major phase II enzymes, 2) suggesting that cryopreserved human hepatocytes may represent a useful experimental system for evaluation of the metabolism, inhibition, and induction of xenobiotics after exposure to various compounds.
Rifampicin is known to induce the metabolism of numerous drugs, including warfarin, digitoxin, ethynylestradiol, glucocorticoids, vitamin D, and thyroxine. 3) In addition, rifampicin and its analogue rifabutin increase their own metabolism after repeated administration to patients. 4) Rifampicin also causes an increase in the urinary ratio of 6b hydroxycortisol to 17 hydroxycorticosterone, indicating the induction of CYP3A4 in vivo. 5, 6) Rifampicin is a potent inducer of CYP3A in primary cultures of human hepatocytes, [7] [8] [9] and omeprazole is a potent inducer of CYP1A in primary cultures of human hepatocytes. [10] [11] [12] [13] There have been reports on the usefulness of the quantitative real-time reverse-transcription polymerase chain reaction method (RT PCR) for the analysis of human CYP1A1 and CYP3A4 mRNA expression in primary cultures of human hepatocytes 10) and mouse cytochrome P450 mRNA expression in mouse liver. 14) However, methods for the quantitative, high-throughput, real-time RT PCR of human ％ CO 2 and 95％ air at 37°C. The medium was then replaced with fresh medium without human epidermal growth factor (hEGF), gentamicin, and amphotericin B, and the cells were cultured for 24 h under 5％ CO 2 and 95％ air at 37°C. The cells were used for experiments at 48 h after inoculation.
Experiments Using Monolayer Cultures of Hepatocytes
After 48 h of inoculation, human hepatocytes were treated with a number of known inducers for an additional 24 or 48 h. Media with the inducers but without hEGF, gentamicin, and amphotericin B were changed daily during treatment. These media were then replaced with fresh media without inducers, hEGF, gentamicin, and amphotericin B, and the cells were cultured for 24 or 48 h under 5％ CO 2 and 95％ air at 37°C. The medium was changed daily. The eŠects of rifampicin and omeprazole were studied at doses of 0.2, 10, and 50 mM. All inducers were dissolved in DMSO to aˆnal vehicle concentration of 0.1％ (v/v). Controls with DMSO untreated cells were included in the experimental design to assess the eŠect of DMSO on mRNA expression. Total RNA was extracted from the hepatocytes using the RneasyMini Kit and QIAshredder TM .
Oligonucleotides
The forward and reverse primers and the TaqMan probes were designed using Primer Express software (Applied Biosystems) from the human mRNA sequence ( Table 1) . Each primer and/or probe was homology searched by an NCBI BLAST search to ensure that it was speciˆc for the target mRNA transcript. The primers and TaqMan probes were synthesized by Sawady Technology Co., Ltd. (Tokyo, Japan). The TaqMan probes contained 6 carboxy‰uoresencin (FAM) at the 5′end and 6 carboxytetramethylrhodamine (TAMRA) at the 3′ end and were designed to hybridize to a sequence located between the PCR primers.
TaqMan RT PCR Conditions
Human total RNA was diluted with yeast tRNA at 50 mg/ml. The RT PCR assay was performed in 50 ml of TaqMan One-Step RT PCR Master Mix Reagents containing 300 nM forward primer, 900 nM reverse primer, 200 nM TaqMan probe, and 6.4 to 100,000 pg of total RNA. Ampliˆcation and detection were performed using the ABI PRISM 7700 Sequence Detector system (Applied Biosystems) with the following proˆle: 1 cycle of 48°C for 30 min, 1 cycle of 95°C of 10 min, and 50 cycles each of 95°C for 15 s and 60°C for 1 min. All sequences are shown from the 5′to 3′end.
Statistical Analysis
Samples were deemed positive at any given cycle when the value of the emitted ‰uorescence was greater than the threshold value calculated by the instrument's software (Sequence Detector Ver. 1.6.3). The threshold cycle (Ct), which is deˆned as the cycle at which PCR ampliˆcation reaches a signiˆcant value (i.e., usually 15 times the standard deviation of the baseline), is given as a mean value. The source of total RNA for the measurement of calibration data was the human adult liver.
The data are expressed as the ratio of target mRNA to GAPDH mRNA, and the data are then shown as a percentage relative to control at each time point. Experiments involving human hepatocyte cultures were performed in triplicate, and results for the ratio of target mRNA to GAPDH mRNA and percentage relative to control at each time point are shown as mean SD of three runs.
RESULTS

Detection of mRNAs Using Quantitative, High-Throughput, Real-Time RT PCR
Pairs of primers and TaqMan probes speciˆc to each phase I enzyme, phase II enzyme, and transporter were generated ( Table 1 ). The sequence of each was obtained from GenBank, and GenBank accession numbers are shown in the table. The positions of the primers and probes were counted from the position of the initiation codon, except for MGST1, ABCA2, and SLC22A3, for which the position of the initiation codon is not known. Analysis was performed in the presence of the TaqMan probes by real-time ‰uores-cence monitoring on an ABI PRISM 7700 Sequence Detector. Table 2 shows the calibration data and limit of quantiˆcation for each mRNA in the total RNA studied. The source of total RNA was the human adult liver pool. The lower limit of quantiˆcation of each of the mRNAs ranged from 6.4 to 4000 pg of total RNA per 50 ml of reaction mixture.
EŠect of Inducers on mRNA Expression
In the present study, the levels of gene expression for phase I enzymes, phase II enzymes, and transporters were evaluated in cultures of human hepatocytes after 48 h exposure to known typical enzyme inducers such as rifampicin and omeprazole. All experiments were performed in the presence of 0.1％ DMSO. Expression data are shown in Table 3 . None of the treatments showed any identiˆable toxic eŠects such as cell death or loss of adhesion of hepatocytes at the study concentrations employed, as assessed by microscopic examination. The levels of CYP1A1, CYP2B6, CYP2C8, CYP3A4, CYP3A5, ADH3, and ABCG1 mRNA in human hepatocytes after exposure to rifampicin were two toˆve times higher than those in controls. The levels of CYP1A1, CYP1A2, CYP1B1, ALDH3, and ALDH6 mRNA after exposure to omeprazole were 2.5 to 224 times higher than those in controls. On the other hand, the levels of ADH3 and ABCB4 mRNA after exposure to omeprazole were 0.27 to 0.5 times lower than those in controls. The time course and eŠects of these doses (2, 10, and 50 mM) on expression of the mRNAs (CYP1A1, CYP1A2, CYP1B1, CYP2B6, CYP2C8, CYP3A4, CYP3A5, ADH3, ALDH3, ALDH6, ABCB4, and ABCG1) were evaluated, and mRNA levels were two times higher or lower than in controls after exposure to rifampicin or omeprazole, as shown in Table 3 . None of the treatments showed any identiˆable toxic eŠects such as cell death or loss of adhesion of hepatocytes at the study concentrations employed, as assessed by microscopic examination. Figures 1 and 2 show the levels of mRNA expression after rifampicin and omeprazole exposure, respectively. The human hepatocytes were treated with rifampicin or omeprazole for 24 and 48 h. The medium with rifampicin or omeprazole were then replaced with fresh medium, and the hepatocytes were cultured for an additional 24 and 48 h (72 and 96 h, respectively, in Figs. 1 and  2 ). Exposure to rifampicin increased the levels of CYP1A1, CYP2B6, CYP2C8, CYP3A4, CYP3A5, The calibration curves show the threshold cycle (Ct) for analysis of total RNA per 50 ml of reaction mixture. The source of total RNA was the human adult liver.
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Vol. 122 (2002) ADH3, and ABCG1 mRNA in a concentrationdependent manner (Fig. 1A, D , E, F, G, H, L). The levels of CYP1A1, CYP2B6, CYP3A4, CYP3A5, and ABCG1 mRNA decreased after a change to media without rifampicin, and levels 48 h after a change to media without rifampicin (96 h in theˆgure) were comparable to those in controls (untreated cells) (Fig. 1A, D, F, G, L) . The levels of CYP2C8 and ADH3 mRNA decreased slightly 48 h after a change to media without rifampicin (Fig. 1E, H) . The levels of CYP1A2, CYP1B1, ALDH3, ALDH6, and ABCB4 mRNA after rifampicin exposure did not change to the levels in controls (Fig. 1B, C, I , J, K). Exposure to omeprazole increased the levels of CYP1A1, CYP1A2, CYP1B1, ALDH3, and ALDH6 mRNA in a concentration-dependent manner, and the levels of these mRNAs decreased after a change to media without omeprazole ( Fig. 2A, B , C, I, J). Exposure to omeprazole increased the levels of CYP2B6 and CYP3A4 mRNA, and the levels of these mRNAs decreased after a change to media without omeprazole (Fig. 2D, F) . Exposure to omeprazole slightly increased the levels of CYP2C8 and CYP3A5 mRNA (Fig. 2E, G) . On the other hand, exposure to omeprazole decreased the levels of ADH3 and ABCB4 mRNA, and the levels of these mRNAs recovered after a change to media without omeprazole (Fig. 2H, K) . Exposure to omeprazole for an additional 24 h decreased the level of ABCG1 mRNA in a concentration-dependent manner, but the level of this mRNA recovered after an additional 48 h of omeprazole exposure (Fig. 2L) .
DISCUSSION
A new analytic method for quantifying mRNA levels in small numbers of human hepatocytes has been developed for phase I enzymes, phase II enzymes, and transporters. This method employs sets of forward and reverse primers and TaqMan probes to hybridize to each target cDNA of phase I enzymes, phase II enzymes, and transporters. Both the primers and/or probes were homology searched by an NCBI BLAST search to ensure that they are speciˆc for the target mRNA transcript. To our knowledge, this is theˆrst Human hepatocytes were treated with rifampicin for 24 and 48 h. The media with rifampicin were then replaced with fresh medium, and the hepatocytes were cultured for an additional 24 and 48 h (72 and 96 h, respectively, in theˆgure). The medium was changed daily. Data are expressed as the ratio of target mRNA to GAPDH mRNA, and data are then shown as a percentage relative to control at each time point. Experiments (cultured human hepatocytes) were performed in triplicate, and data are shown as the mean value for three runs. A: CYP1A1; B: CYP1A2; C: CYP1B1; D: CYP2B6; E: CYP2C8; F: CYP3A4; G: CYP3A5; H: ADH3; I: ALDH3; J: ALDH6; K: ABCB4; L: ABCG1.
Fig. 2. Time Course and EŠects on Levels of mRNA Expression after Omeprazole Exposure
Human hepatocytes were treated with omeprazole for 24 and 48 h. The media with omeprazole were then replaced with fresh medium, and the hepatocytes were cultured for an additional 24 and 48 h (72 and 96 h, respectively, in theˆgure). The medium was changed daily. Data are expressed as the ratio of target mRNA to GAPDH mRNA, and data are then shown as a percentage relative to control at each time point. Experiments (cultured human hepatocytes) were performed in triplicate, and data are shown as the mean value for three runs. A: CYP1A1; B: CYP1A2; C: CYP1B1; D: CYP2B6; E: CYP2C8; F: CYP3A4; G: CYP3A5; H: ADH3; I: ALDH3; J: ALDH6; K: ABCB4; L: ABCG1. application of the real-time one-step RT PCR TaqMan method to the study of phase I enzymes, phase II enzymes, and transporters. In the present study, the TaqMan method was found to be exquisitely sensitive and to permit quantitative evaluation, and it was found that the quantiˆcation limit was two times higher or lower than in control. This is in contrast to existing methods such as Northern blotting, which often require micrograms of total RNA. This method could therefore prove to be particularly useful in studies where the amount of target mRNA may be very low, as in cultured cells. In addition, this method does not require electrophoretic gels to be run, and the assay can be performed in a high-throughput manner using 96 well or 384 well plates.
The hybridization e‹ciency to target mRNA diŠered according to the design position of the reverse primer because the RT reaction carried out at 48°C preserved the higher-order structure of the mRNA. Therefore the position of the reverse primer set the upper limit of the hybridization e‹ciency to the target mRNA. This being the case, the design positions of sequences that can select an enzyme family are limited. It is thus more di‹cult to design both primers and probes for use in one-step RT PCR compared with two-step RT PCR. This method avoids complicated operations such as the need to perform separate reactions for RT and PCR, assuming that the set of primers and probes is designed to target selectively mRNA in which the high-order structure is preserved. To standardize the reaction e‹ciency, the concentrations of the forward primer, the reverse primer, and the TaqMan probe were 300 nM, 900 nM, and 200 nM, respectively. With regard to TaqMan RT PCR conditions, the concentration of the reverse primer was three times higher than that of the forward primer due to an increase in hybridization e‹ciency to mRNA in the RT reaction. The calculated standard values using the human total RNA were aŠected by the quantity of the target mRNA in the human total RNA. Therefore the same human total RNA was used in this study.
In standard induction studies, drug-metabolizing enzyme activities are evaluated in liver samples after repeated administration to female rats. However, species diŠerences in the induction of drug-metabolizing enzymes and transporters are frequently observed in the metabolism and transport of xenobiotics. Studies employing human hepatocytes are useful in overcoming this problem. The quantiˆcation of enzyme and transporter induction has been achieved primarily by measuring changes in the metabolism and transport of enzyme-and transporter-selective substrates or by direct quantiˆcation of enzyme and transporter proteins using speciˆc antibodies and Western blotting. However, using these analytic methods for quantifying enzyme activities and protein levels, it is di‹cult to measure phase I enzymes, phase II enzymes, and transporters in the same sample because a large amount of sample is required for measurement. In the present study, a new analytic method for quantifying mRNA levels was used to measure phase I enzymes, phase II enzymes, and transporters in the same sample obtained from small numbers of human hepatocytes. Recently, direct studies of enzyme mRNA expression have been used because up-regulation of enzyme gene transcription and the subsequent increase in protein levels are thought to be primarily responsible for the enhanced metabolic function of enzymes after exposure to inducers. [15] [16] [17] It has been suggested that the induction levels show a correlation between enzyme activities or protein levels and mRNA levels after exposure to inducers. 18, 19) One possible exception is the induction of CYP2E1 by ethanol and isoniazid, which is thought to result either from protein stabilization 20) or increased protein translation. 21) Therefore we considered that rapid estimation should be possible by evaluating the changes in the mRNA levels of target enzymes and transporters and then evaluating the changes in corresponding protein and activity levels. It is also possible that mRNA induction occurs to counter a reduction in activity due to inhibition of the target enzyme or transporter. Therefore we carefully considered the targets for evaluating changes in mRNA levels when mRNA levels were not correlated with protein or activity levels.
The results shown in Fig. 1 are similar to those shown in Table 3 after exposure to rifampicin. However, the exposure to omeprazole 50 mM for 48 h had no remarkable eŠect on CYP2B6 or CYP3A4 mRNA expression (Table 3) . On the other hand, the levels of CYP2B6 and CYP3A4 mRNA after exposure to omeprazole 50 mM for 48 h, in the same hepatocytes increased to levels approximately three and seven times higher than those in controls, respectively (Fig. 2) . The levels of CYP1A1, CYP1A2, CYP1B1, ALDH3, and ALDH6 mRNA shown in The eŠects of rifampicin and omeprazole were studied at doses of 50 mM. Data are expressed as the ratio of target mRNA to GAPDH mRNA. Experiments (cultured human hepatocytes) were performed in triplicate, and data are shown as mean±SD of three runs. Values in parentheses indicate percentages relative to control. Fig. 2 after exposure to omeprazole 50 mM for 48 h were about two times higher than those shown in Table 3. It is considered that the sensitivity of hepatocytes after drug exposure was due to experimental variation. However, the biochemical cause of this diŠerence is unknown. Therefore we feel that it is important to obtain measurements using positive controls such as rifampicin for CYP3A4 mRNA and omeprazole for CYP1A1 and CYP1A2 mRNA. We are planning to perform additional studies to identify appropriate positive controls for each enzyme and transporter.
As shown in Fig. 2 , the level of ABCG1 mRNA decreased to 50％ after 24 h exposure to omeprazole 50 mM, whereas the level of ABCG1 mRNA was 70％ after 48 h exposure to omeprazole 50 mM, as shown in Table 3 . Exposure to a drug at a dose of 50 mM for 48 h is not the most suitable method for identifying mRNAs that are regulated by drug exposure. However, at the present time, even using highthroughput analysis, it is di‹cult to measure mRNA levels for more than 100 enzymes and transporters at various concentrations and at multiple time points. We therefore investigated exposure to compounds at the dose of 50 mM for 48 h for initial screening in the present study.
In conclusion, the results of the present study demonstrate the applicability of quantitative realtime RT PCR to the evaluation of gene induction and recovery of drug-metabolizing enzymes and transporters after exposure to drugs in human hepatocytes. This method has the advantages of high sensitivity, simplicity, and linearity of quantiˆcation over a wide range of mRNA concentrations, making it particularly suitable for evaluating large numbers of samples, as required in expression proˆle determinations. We will present further results demonstrating the usefulness of this system employing human hepatocytes as in vitro induction studies.
